Literature DB >> 5635319

Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange).

S Sabin, J A Merritt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5635319     DOI: 10.7326/0003-4819-68-1-1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  11 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

Review 2.  Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.

Authors:  Katsutoshi Naruse; Wei Tang; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 3.  The management of acute hepatic failure.

Authors:  S Sherlock; S P Parbhoo
Journal:  Postgrad Med J       Date:  1971-07       Impact factor: 2.401

4.  [Brain edema. A cause of death in endogenous hepatic coma].

Authors:  H Thölen
Journal:  Klin Wochenschr       Date:  1972-03-15

5.  Treatment of hepatic encephalopathy.

Authors:  P J Toghill
Journal:  Postgrad Med J       Date:  1969-03       Impact factor: 2.401

6.  Exchange transfusion in the treatment of patients with acute hepatitis in coma.

Authors:  R A Rivera; R L Slaughter; H W Boyce
Journal:  Am J Dig Dis       Date:  1970-06

7.  The treatment of hepatitis.

Authors:  S Sherlock
Journal:  Bull N Y Acad Med       Date:  1969-02

Review 8.  Artificial liver support: future aspects.

Authors:  Katsutoshi Naruse
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

9.  Development and perspectives of perfusion treatment for liver failure.

Authors:  Katsutoshi Naruse; Hiroshi Nagashima; Yasuyuki Sakai; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 10.  Role of artificial liver support in hepatic encephalopathy.

Authors:  V Stadlbauer; G A K Wright; R Jalan
Journal:  Metab Brain Dis       Date:  2008-12-21       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.